Inventor
JIAN-FENG LU
Inventor
US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
C07KPeptides33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C12YEnzymes7%
PatentTitleYear
12,312,413Antibodies and methods for making and using the same202512,043,662Angiopoietin 2, VEGF dual antagonists202411,845,801IL-15 prodrugs and methods of use thereof202311,746,147Angiopoietin 2, VEGF dual antagonists202311,505,618Antibodies and methods for making and using the same2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to ASKGENE PHARMA INC (5)· patent assignee history
2022–2025Patents assigned to JIANGSU AOSAIKANG PHARM CO LTD (3)· patent assignee history
2022–2025Based in US· patent location history
2025Patents assigned to Jiangsu AoSaiKang Ph (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ASKGENE PHARMA INC | 5 | 2022–2025 |
| JIANGSU AOSAIKANG PHARM CO LTD | 3 | 2022–2025 |
| Jiangsu AoSaiKang Ph | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 5 | 2022–2025 |